idarubicin Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2/3 (1)

Interventional (1)

Fujian Medical University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadleukemia

I am/have/hadacute promyelocytic leukemia

I am/have/hadheart failure

I am/have/hadejection fraction

I am/have/hadinduction chemotherapy

I am/have/hadmyocardial infarction

I am/have/hadremission

I am/have/hadinfarction

I am/have/hadarrhythmia

added new label for I am/have/had

more

I am looking for

I am looking foridarubicin

I am looking forcytarabine

I am looking foranthracyclines

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients

This study evaluates Idarubicin (IDA) in combination with the intermediate-dose cytarabine, compared with intermediate-dose cytarabine alone, as a consolidation treatment for elderly AML in first remission.

anthracyclines

ejection fraction

cytarabine

acute promyelocytic leukemia

idarubicin

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.